Antibiotic interactions that select against resistance

Nature

Volumn 446, Issue 7136, 2007, Pages 668-671

  Chait, Remy ^a   Craney, Allison ^a   Kishony, Roy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN;

ALLELE; ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; COLIFORM BACTERIUM; WILD POPULATION;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BIOASSAY; CONCENTRATION (PARAMETERS); DRUG COMPETITION; DRUG INHIBITION; DRUG POTENTIATION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 34247277741     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05685     Document Type: Article

References (30)

1. Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10, S122-S129 (2004).
2. Golan, D. E. et al. (eds). Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy (Lippincott Williams & Wilkins, Philadelphia, 2005).
3. Pillai, S. K., Moellering, R. C. & Eliopoulos, G. M. in Antibiotics in Laboratory Medicine (ed. Lorian, V.) 365-440 (Lippincott Williams & Wilkins, Philadelphia, 2005).
4. Yim, G., Wang, H. H. M. & Davies, J. The truth about antibiotics. Int. J. Med. Microbiol. 296, 163-170 (2006).
5. Czaran, T. L., Hoekstra, R. F. & Pagie, L. Chemical warfare between microbes promotes biodiversity. Proc. Natl Acad. Sci. USA 99, 786-790 (2002).
6. Klein, M. & Schorr, S. E. The role of bacterial resistance in antibiotic synergism and antagonism. J. Bacteriol. 65, 454-465 (1953).
7. Lipsitch, M. & Levin, B. R. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41, 363-373 (1997).
8. Keith, C. T., Borisy, A. A. & Stockwell, B. R. Multicomponent therapeutics for networked systems. Nature Rev. Drug Discov. 4, 71-78 (2005).
9. Loewe, S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3, 285-290 (1953).
10. Yeh, P., Tschumi, A. I. & Kishony, R. Functional classification of drugs by properties of their pairwise interactions. Nature Genet. 38, 489-494 (2006).
11. Fraser, T. R. The antagonism between the actions of active substances. BMJ 2, 485-487 (1872).
12. Chopra, I. & Roberts, M. Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232-260 (2001).
13. Walsh, C. Antibiotics: Actions, Origins, Resistance, 335 (American Society for Microbiology Press, Washington DC, 2003).
14. Poole, K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56, 20-51 (2005).
15. Hillen, W. & Berens, C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48, 345-369 (1994).
16. Singer, M. et al. A collection of strains containing genetically linked alternating antibiotic-resistance elements for genetic-mapping of Escherichia coli. Microbiol. Rev. 53, 1-24 (1989).
17. Bjarnason, J., Southward, C. M. & Surette, M. G. Genomic profiling of iron-responsive genes in Salmonella enterica serovar typhimurium by high-throughput screening of a random promoter library. J. Bacteriol. 185, 4973-4982 (2003).
18. Kishony, R. & Leibler, S. Environmental stresses can alleviate the average deleterious effect of mutations. J. Biol. 2, 14.1-14.10 (2003).
19. Lenski, R. E., Simpson, S. C. & Nguyen, T. T. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J. Bacteriol. 176, 3140-3147 (1994).
20. Lenski, R. E. et al. Epistatic effects of promoter and repressor functions of the Tn10 tetracycline-resistance operon on the fitness of Escherichia coli. Mol. Ecol. 3, 127-135 (1994).
21. Yang, W. R. et al. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J. Biol. Chem. 279, 52346-52352 (2004).
22. Whittle, G. et al. Identification of a new ribosomal protection type of tetracycline resistance gene, tet(36), from swine manure pits. Appl. Environ. Microbiol. 69, 4151-4158 (2003).
23. Hegreness, M., Shoresh, N., Hartl, D. & Kishony, R. An equivalence principle for the incorporation of favorable mutations in asexual populations. Science 311, 1615-1617 (2006).
24. Chao, L. Unusual interaction between the target of nalidixic acid and novobiocin. Nature 271, 385-386 (1978).
25. Deeks, S. G. Treatment of anti retroviral-drug-resistant HIV-1 infection. Lancet 362, 2002-2011 (2003).
26. Tsui, W. H. W. et al. Dual effects of MLS antibiotics: Transcriptional modulation and interactions on the ribosome. Chem. Biol. 11, 1307-1316 (2004).
27. Drlica, K. & Hooper, D. C. in Quinolone Antimicrobial Agents (eds Hooper, D.C. & Rubinstein, E.) 19-40 (ASM Press, Washington DC, 2003).
28. Weinreich, D. M., Delaney, N. F., DePristo, M. A. amp; Hartl, D. L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111-114 (2006).
29. 2 regulatory elements. Nucleic Acids Res. 25, 1203-1210 (1997).
30. Elowitz, M. B., Levine, A. J., Siggia, E. D. & Swain, P. S. Stochastic gene expression in a single cell. Science 297, 1183-1186 (2002).